Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The present study aimed to systematically compare overall loss to follow-up, discontinuation rates because of adverse events and discontinuation rates because of a lack of efficacy in published studies assessing the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) compared to other second-generation antidepressants in treating outpatients with major depressive disorder (MDD). We searched MEDLINE, Embase, The Cochrane Library, PsychLit and the International Pharmaceutical Abstracts from 1980 to 2004 (April). Twenty double-blinded, randomized controlled trials met our eligibility criteria and compared SSRIs to other second-generation antidepressants in adult outpatients with MDD. Pooled relative risks of discontinuation rates because of (i) any reason (overall loss to follow-up), (ii) adverse events and (iii) a lack of efficacy did not differ substantially between SSRIs as a class and other second-generation antidepressants. Taking the similar efficacy of second-generation antidepressant into account, our findings suggest that clinicians can focus on other practically or clinically relevant considerations such as costs, differences in side-effect profiles, onset of action or aspects of health-related quality of life to tailor a treatment to an individual patient's needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 2×
“…Coleman et al., 1999; Croft et al., 1999; Coleman et al., 2001) and nefazodone (Feiger et al., 1996) lead to fewer sexual side-effects and an improved sleep profile (Armitage et al., 1997; Gillin et al., 1997; Rush et al., 1998; Clayton et al., 2002) than fluoxetine, paroxetine and sertraline.”
BackgroundSelective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · cited 2×
“Compared to TCAs, second-generation antidepressants show similar efficacy (Song et al., 1993; Geddes et al., 2004; Williams et al., 2000) but a greater tolerability and a reduced toxicity when overdosed (Montgomery et al.”
BackgroundRush, A. J., Armitage, R., Gillin, J. C., Yonkers, K. A., Winokur, A., Moldofsky, H., Vogel, G. W., Kaplita, S. B., Fleming, J. B., Montplaisir, J., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00092-4 · Cited by 215 · cited 2×
“…Coleman et al., 1999; Croft et al., 1999; Coleman et al., 2001) and nefazodone (Feiger et al., 1996) lead to fewer sexual side-effects and an improved sleep profile (Armitage et al., 1997; Gillin et al., 1997; Rush et al., 1998; Clayton et al., 2002) than fluoxetine, paroxetine and sertraline.”
BackgroundDouble-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215 · cited 5×
“, 2002), paroxetine (Benkert et al., 2000; Schatzberg et al., 2002) or sertraline (Rudolph and Feiger, 1999; Behnke et al.”
BackgroundMethodResultInfluentialRudolph, R. L., & Feiger, A. D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00067-1 · Cited by 158 · cited 3×
“…with 2314 patients compared SSRIs to venlafaxine (Table 2) (Dierick et al., 1996; Tylee et al., 1997; Costa e Silva, 1998; McPartlin et al., 1998; Alves et al., 1999; Rudolph and Feiger, 1999; Silverstone and Ravindran, 1999; Ballus et al., 2000; Mehtonen et al., 2000; De Nayer et al., 2002).”
BackgroundBupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0309 · Cited by 150
Gillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0502 · Cited by 104
Armitage, R., Yonkers, K., Cole, D., & Rush, A. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00004 · Cited by 97
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
The effects of probiotics on depressive symptoms in humans: a systematic review
Wallace, C. J. K., & Milev, R. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0138-2 · Cited by 471
“Even when they start to become effective, the side effects associated with them cause an estimated 15–30% of patients to discontinue their use [51].”
BackgroundSlykerman, R. F., Hood, F., Wickens, K., Thompson, J. M. D., Barthow, C., Murphy, R., Kang, J., Rowden, J., Stone, P., Crane, J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.013 · Cited by 422
“Furthermore it takes several weeks for the therapeutic effect of antidepressants to appear and there is a 15–30% discontinuation rate (Gartlehner et al., 2005).”
BackgroundBupropion: pharmacology and therapeutic applications
Foley, K. F., DeSanty, K. P., & Kast, R. E. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1249 · Cited by 352
Metadata
- Authors
- Gartlehner, G., Hansen, R. A., Carey, T. S., Lohr, K. N., Gaynes, B. N., & Randolph, L. C.
- Venue
- International Clinical Psychopharmacology
- Published
- 2005-03
- Volume
- 20
- Issue
- 2
- Pages
- 59-69
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W1996236818
- Cited by
- 60
- References
- 10
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/00004850-200503000-00001
- The paper
- Gartlehner, G., Hansen, R. A., Carey, T. S., Lohr, K. N., Gaynes, B. N., & Randolph, L. C. (2005). Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200503000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.